ATYR vs TLRY · rev $190.0K vs rev $915.5M
aTyr Pharma, Inc. (ATYR) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
ATYR currently screens at market cap $471.7M. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the ATYR and TLRY stock pages for the full models.
Not investment advice.